Yuji Inagaki Selected Research

Infections

1/2023	Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF-V600E-positive non-small cell lung cancer: A case report.
5/2016	Effect of Hangeshashinto on calprotectin expression in human oral epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuji Inagaki Research Topics

Disease

11	Neoplasms (Cancer) 03/2023 - 12/2004
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 01/2020
10	Periodontitis 01/2021 - 10/2014
5	Hepatocellular Carcinoma (Hepatoma) 02/2016 - 12/2010
3	Neoplasm Metastasis (Metastasis) 09/2023 - 09/2014
2	Thrombocytopenia (Thrombopenia) 10/2023 - 02/2014
2	Anemia 10/2023 - 07/2010
2	Disease Progression 09/2023 - 03/2023
2	Fever (Fevers) 01/2023 - 04/2020
2	Paralysis (Palsy) 01/2023 - 01/2023
2	Infections 01/2023 - 05/2016
2	Adenocarcinoma of Lung 01/2023 - 10/2020
2	Bone Resorption 01/2021 - 10/2014
2	Alveolar Bone Loss 09/2020 - 01/2020
2	Inflammation (Inflammations) 08/2020 - 10/2014
2	Diabetes Mellitus 10/2019 - 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 11/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023
1	Pulmonary Alveolar Proteinosis 10/2023
1	Communicable Diseases (Infectious Diseases) 04/2023
1	Malignant Pleural Effusion 03/2023
1	Disseminated Intravascular Coagulation 01/2023
1	Cerebral Infarction 01/2023
1	Chills 01/2023
1	Radiation Pneumonitis 01/2023
1	Hoarseness 01/2023
1	Vocal Cord Paralysis 01/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Chronic Periodontitis 10/2022
1	Bites and Stings (Sting) 10/2022
1	Lung Neoplasms (Lung Cancer) 07/2022
1	Exanthema (Rash) 04/2020
1	Cough 04/2020
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 04/2020
1	Vasculitis (Vasculitides) 04/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2020
1	Adenocarcinoma 04/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Pleural Effusion (Pleural Effusions) 01/2020
1	Paresis (Hemiparesis) 01/2019
1	Multi-centric Castleman's Disease 09/2016

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 12/2004
4	NivolumabIBA 07/2022 - 01/2020
4	Antimicrobial PeptidesIBA 08/2020 - 08/2011
3	osimertinibIBA 09/2023 - 10/2020
3	ErbB Receptors (EGF Receptor)IBA 09/2023 - 10/2020
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020 - 08/2011
3	Advanced Glycation End ProductsIBA 10/2019 - 07/2013
2	Messenger RNA (mRNA)IBA 10/2022 - 09/2014
2	InterferonsIBA 10/2022 - 02/2014
2	LipopolysaccharidesIBA 10/2022 - 08/2020
2	CytokinesIBA 10/2022 - 10/2014
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Lysophospholipase (Phospholipase B)IBA 09/2020 - 01/2020
2	lysophosphatidic acidIBA 09/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 04/2020 - 06/2013
2	ResveratrolIBA 10/2014 - 10/2014
2	LigandsIBA 10/2014 - 06/2014
2	DefensinsIBA 09/2014 - 08/2011
1	Epidermal Growth Factor (EGF)IBA 11/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2023
1	AutoantibodiesIBA 10/2023
1	Surface-Active Agents (Surfactants)IBA 10/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2023
1	Liposomes (Liposome)IBA 04/2023
1	Carboplatin (JM8)FDA LinkGeneric 03/2023
1	130-nm albumin-bound paclitaxelIBA 03/2023
1	Bevacizumab (Avastin)FDA Link 03/2023
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2023
1	ThrombomodulinIBA 01/2023
1	trametinibIBA 01/2023
1	dabrafenibIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	Gingipain Cysteine EndopeptidasesIBA 10/2022
1	p38 Mitogen-Activated Protein KinasesIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Interleukin-8 (Interleukin 8)IBA 10/2022
1	Small Interfering RNA (siRNA)IBA 10/2022
1	RamucirumabIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 03/2021
1	Therapeutic UsesIBA 01/2021
1	Nylons (Nylon)IBA 01/2021
1	Carcinoembryonic AntigenIBA 10/2020
1	Lipocalin-2IBA 08/2020
1	Clopidogrel (Plavix)FDA Link 04/2020
1	CarbohydratesIBA 04/2020
1	Culture MediaIBA 04/2020
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 04/2020
1	SteroidsIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	shogaolIBA 10/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	GlucocorticoidsIBA 09/2016

Therapy/Procedure

4	Therapeutics 01/2020 - 02/2014
3	Oral Administration 01/2023 - 10/2014
3	Ligation 01/2021 - 10/2014
1	Aftercare (After-Treatment) 01/2023
1	Radiotherapy 01/2023